Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:medical_procedure
|
| gptkbp:advantage |
precise margin control
high cure rate tissue sparing |
| gptkbp:alternativeName |
gptkb:Mohs_surgery
chemosurgery |
| gptkbp:anesthesia |
local anesthesia
|
| gptkbp:certification |
American College of Mohs Surgery
American Society for Mohs Surgery |
| gptkbp:complication |
bleeding
infection nerve damage scarring |
| gptkbp:contraindication |
certain melanoma subtypes
metastatic skin cancer |
| gptkbp:coveredBy |
most health insurance plans
|
| gptkbp:developedBy |
gptkb:Frederic_E._Mohs
|
| gptkbp:field |
oncology
dermatology |
| gptkbp:firstDescribed |
1938
|
| gptkbp:followedBy |
regular skin checks
|
| gptkbp:frequency |
increasing
|
| gptkbp:guideline |
gptkb:National_Comprehensive_Cancer_Network
gptkb:American_Academy_of_Dermatology |
| gptkbp:indication |
recurrent tumors
large tumors tumors in cosmetically sensitive areas tumors with ill-defined borders |
| gptkbp:namedAfter |
gptkb:Frederic_E._Mohs
|
| gptkbp:performedBy |
gptkb:dermatologist
dermatologic surgeon |
| gptkbp:region |
worldwide
|
| gptkbp:restored |
may require local flap
may require skin graft |
| gptkbp:setting |
outpatient
|
| gptkbp:step |
microscopic examination
tumor removal tissue mapping margin assessment |
| gptkbp:successRate |
up to 97% for recurrent basal cell carcinoma
up to 99% for primary basal cell carcinoma |
| gptkbp:trainer |
fellowship in Mohs surgery
|
| gptkbp:usedFor |
gptkb:cancer
gptkb:dermatofibrosarcoma_protuberans basal cell carcinoma skin cancer treatment melanoma in situ |
| gptkbp:bfsParent |
gptkb:dermatofibrosarcoma_protuberans
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Mohs micrographic surgery
|